LingYi Cai
Overview
Explore the profile of LingYi Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia W, Zhang Y, Wang T, Liu C, Tu J, Shi G, et al.
Comb Chem High Throughput Screen
. 2024 Aug;
PMID: 39136509
Background: In this study, we used immune repertoire (IR) sequencing technology to profile the diversity of peripheral blood T cell receptors and used transcriptomics to profile the gene expression of...
2.
Cai L, Anastassiou D
Bioinformatics
. 2024 Apr;
40(5).
PMID: 38662553
Summary: Existing clustering methods for characterizing cell populations from single-cell RNA sequencing are constrained by several limitations stemming from the fact that clusters often cannot be homogeneous, particularly for transitioning...
3.
Cai L, Kolonin M, Anastassiou D
Cancer Metastasis Rev
. 2024 Mar;
43(3):977-980.
PMID: 38466528
We identified a progenitor cell population highly enriched in samples from invasive and chemo-resistant carcinomas, characterized by a well-defined multigene signature including APOD, DCN, and LUM. This cell population has...
4.
Zhang Z, Sun C, Cai L, Chen Y, Zhou X, Chen S, et al.
Clin Lab
. 2024 Feb;
70(2).
PMID: 38345995
Background: Philadelphia chromosome-positive acute myeloid leukemia (Ph+ AML) is a rare leukemia subtype first classified by the World Health Organization in 2016. The incidence of Ph+ AML is approximately 0.5...
5.
Shi J, Zhang P, Su H, Cai L, Zhao L, Zhou H
Pharmgenomics Pers Med
. 2021 Jul;
14:849-858.
PMID: 34285553
Objective: To analyze the changes in downstream genes, signaling pathways, and proteins based on the difference of microRNA (miRNA) expression in neuroblastoma (NB). Methods: GSE128004 second-generation sequencing expression data were...
6.
Zhu K, Cai L, Cui C, de Los Toyos J, Anastassiou D
PLoS Comput Biol
. 2021 Jul;
17(7):e1009228.
PMID: 34283835
During the last ten years, many research results have been referring to a particular type of cancer-associated fibroblasts associated with poor prognosis, invasiveness, metastasis and resistance to therapy in multiple...
7.
Jin J, Liu C, Yu S, Cai L, Sitrakiniaina A, Gu R, et al.
Aging (Albany NY)
. 2021 Jun;
13(12):16144-16164.
PMID: 34115610
Background: Lung adenocarcinoma (LUAD) is a heterogeneous disease characterized by high mortality and poor prognosis. Ferroptosis, a newly discovered iron-dependent type of cell death, has been found to play a...
8.
Yu S, Cai L, Liu C, Gu R, Cai L, Zhuo L
Mol Med
. 2021 Apr;
27(1):36.
PMID: 33832428
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world, and its 5-year survival rate is less than 20%, despite various treatments being available. Increasing...